The company's EPS and revenue growth don't match its share p...
The company's EPS and revenue growth don't match its share price decline, hinting at possible over-hype or other factors. Last year's performance suggests unresolved issues. Investors should consider financial health and potential risks before investing.
Shareholders in Shandong Weigao Group Medical Polymer (HKG:1066) Are in the Red If They Invested Three Years Ago
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment